Natixis Advisors LLC Has $33.34 Million Stake in Humana Inc. (NYSE:HUM)

Natixis Advisors LLC raised its position in Humana Inc. (NYSE:HUM - Free Report) by 36.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 131,418 shares of the insurance provider's stock after buying an additional 35,043 shares during the period. Natixis Advisors LLC owned 0.11% of Humana worth $33,342,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. FPC Investment Advisory Inc. acquired a new position in Humana in the fourth quarter valued at about $27,000. Centricity Wealth Management LLC bought a new position in shares of Humana in the fourth quarter worth about $30,000. LFA Lugano Financial Advisors SA raised its stake in shares of Humana by 56.3% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock worth $32,000 after acquiring an additional 45 shares during the last quarter. OFI Invest Asset Management bought a new position in shares of Humana in the fourth quarter worth about $33,000. Finally, Atwood & Palmer Inc. raised its stake in shares of Humana by 64.5% during the fourth quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider's stock worth $39,000 after buying an additional 60 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

HUM has been the subject of a number of recent research reports. Morgan Stanley dropped their price target on shares of Humana from $301.00 to $285.00 and set an "equal weight" rating for the company in a research note on Wednesday, February 12th. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $283.00 target price on shares of Humana in a research note on Wednesday, February 12th. Cantor Fitzgerald reaffirmed a "neutral" rating and issued a $290.00 target price on shares of Humana in a research note on Wednesday, February 12th. Barclays upped their target price on shares of Humana from $255.00 to $270.00 and gave the company an "equal weight" rating in a research note on Thursday, February 13th. Finally, Truist Financial upped their target price on shares of Humana from $260.00 to $290.00 and gave the company a "hold" rating in a research note on Monday, January 6th. Nineteen equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $285.68.

Remove Ads

Humana Stock Down 0.3 %

HUM traded down $0.72 during trading hours on Thursday, hitting $266.62. 1,068,597 shares of the company's stock were exchanged, compared to its average volume of 1,712,095. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $406.46. The stock's 50-day moving average is $271.43 and its two-hundred day moving average is $278.21. The stock has a market cap of $32.18 billion, a price-to-earnings ratio of 26.80, a PEG ratio of 2.05 and a beta of 0.57. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68.

Humana (NYSE:HUM - Get Free Report) last announced its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Sell-side analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.33%. The ex-dividend date is Friday, March 28th. Humana's dividend payout ratio is currently 35.58%.

Insider Buying and Selling at Humana

In related news, insider Timothy S. Huval sold 3,703 shares of the firm's stock in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the transaction, the insider now directly owns 8,181 shares of the company's stock, valued at approximately $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.37% of the company's stock.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.